Logo image
Sign in
The QUIDAM study: Hydroquinidine therapy for the management of Brugada syndrome patients at high arrhythmic risk
Journal article   Open access   Peer reviewed

The QUIDAM study: Hydroquinidine therapy for the management of Brugada syndrome patients at high arrhythmic risk

Antoine Andorin, Jean-Baptiste Gourraud, Jacques Mansourati, Swanny Fouchard, Herve Le Marec, Philippe Maury, Philippe Mabo, Jean-Sylvain Hermida, Jean-Claude Deharo, Béatrice Delasalle, …
Heart Rhythm, Vol.14(8), pp.1147-1154
2017

Abstract

Repolarization Quinidine Arrhythmia Implantable cardioverter–defibrillator Brugada syndrome
url
Find in HALView

Metrics

1 Record Views

Details

Logo image